[Federal Register Volume 85, Number 175 (Wednesday, September 9, 2020)]
[Notices]
[Page 55689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19868]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-704]


Bulk Manufacturer of Controlled Substances Application: Nanosyn 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Nanosyn Inc. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substances. Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before November 9, 
2020. Such persons may also file a written request for a hearing on the 
application on or before November 9, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 6, 2020, Nanosyn Inc., 3331 Industrial Drive, 
Suite B, Santa Rosa, California 95403-2062, applied to be registered as 
an bulk manufacturer of the following basic class(es) of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Oxymorphone............................     9652  II
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company is a contract manufacturer. At the request of the 
company's customers, it manufactures derivatives of controlled 
substances in bulk form.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-19868 Filed 9-8-20; 8:45 am]
BILLING CODE P